James Antinnes, MD
Orthopaedic Surgery of the Spine · Hattiesburg, MSNPI 1215966130
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,083 of the $1,693 with a category attached, or 64.0%. Stryker accounts for 80.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2020 at $1,147 and has fallen 90.2% since, to $113 in 2025.
Across 27 payments — averaging $62.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- Boston Scientific$167
- Johnson & Johnson$60
- Globus Medical$55
- Vertex$18
- Medtronic$13
- plus $13 from 1 others
What the payments were for
- Travel & lodging$61036%
- Food & beverage$1,08364%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 15 | $1,368 |
| Boston Scientific | 6 | $167 |
| Johnson & Johnson | 2 | $60 |
| Globus Medical | 1 | $55 |
| Vertex | 1 | $18 |
| Medtronic | 1 | $13 |
| Mallinckrodt Enterprises LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few orthopaedic surgery of the spine providers in Mississippito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 66 | $710 |
| Gabapentin | 71 | $518 |
| Methylprednisolone | 82 | $483 |
| Ketorolac Tromethamine | 32 | $290 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $162 |
| Clindamycin Hcl | 15 | $158 |
| Meloxicam | 39 | $84 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $80 |
| Celecoxib | 18 | $79 |
| Tizanidine Hcl | 15 | $31 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Hattiesburg
- Michael PattersonHattiesburg$274
- Edward SmithMeridian$259K
- Justin HallColumbus$52K
- Kenny EdwardsColumbus$41K
- Graham CalvertJackson$23K
- Robert McGuireJackson$7K
- David VecchioneTupelo$7K
- Dora PelletierJackson$3K
- James BarrettJackson$3K
- Kendall BlakeJackson$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.